Early Breast Cancer

Once someone goes through 12 consecutive months with no menstrual period, perimenopause is over and the official transition to postmenopausal life has occurred.

Fezolinetant is one of only two nonhormonal medications approved by the Food and Drug Administration (FDA) to treat menopause. The other, paroxetine, was a medication already approved for mood disorders.

According to Dr. Stephanie Faubion, author The New Rules of Menopause, the mean age of women to go into menopause is 52. Going into menopause after 45 is considered normal, although many women do experience it earlier.

Black women are significantly more likely to experience frequent hot flashes and night sweats than are white women, and on average their symptoms last more than three years longer.

Somewhere between 40% and 60% of women report having sleep problems during the menopausal years. This fits with studies showing that the closer women get to menopause, the more sleep troubles they experience.

Changes to your menstrual cycle are usually a normal part of perimenopause. But in some cases, abnormal bleeding may require further evaluation to rule out a more serious condition.

Brain fog, excessive hair growth, eye issues, acne, joint problems, mood changes and bruising are all symptoms of menopause. Excessive hunger is not associated with the condition.

The truth is that menopausal hormone therapy is very effective for some symptoms of menopause and a good choice for many women. Today, several hormone therapy products are approved by the Food and Drug Administration (FDA) to treat the symptoms of menopause.

A little over seven years is the average time women have menopausal symptoms, although that can vary dramatically for each woman.

Menopause copycats include pregnancy, Hyperthyroidism or hypothyroidism, heart disease, endometrial cancer, autoimmune disorders, anxiety, depression, sleep apnea, anemia and uterine fibroids